Pyrazinamide and Sertraline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pyrazinamide (pyrazinamide) and Sertraline (sertraline hydrochloride). Common drug interactions include anaemia among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Pyrazinamide and Sertraline. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Pyrazinamide?

Pyrazinamide has active ingredients of pyrazinamide. It is often used in tuberculosis. eHealthMe is studying from 10,062 Pyrazinamide users. Check the latest studies of Pyrazinamide.

What is Sertraline?

Sertraline has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 153,304 Sertraline users. Check the latest studies of Sertraline.



On Jul, 06, 2026

18 people who take Pyrazinamide and Sertraline together, and have interactions are studied.

Pyrazinamide and Sertraline drug interactions.

What are the common drug interactions of Pyrazinamide and Sertraline, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Electrocardiogram qt prolonged
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Hypokalaemia (low potassium)
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  6. Vomiting
  7. Adjustment disorder with depressed mood
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  10. Diarrhoea

male:

  1. Pain
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Burning sensation
  4. Chest pain
  5. Chronic kidney disease
  6. Drug hypersensitivity
  7. Eosinophil count increased
  8. Hypersensitivity
  9. Impaired healing
  10. Local swelling (swelling at the site of some application of substance or injury)

What are the common drug interactions of Pyrazinamide and Sertraline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug hypersensitivity
  2. Eosinophil count increased
  3. Long qt syndrome (disorder of the heart's electrical system)
  4. Rash

30-39:

  1. Face oedema (swelling of face)
  2. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  3. Visual impairment

40-49:

  1. Anaemia (lack of blood)
  2. Electrocardiogram qt prolonged
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Hypokalaemia (low potassium)
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  6. Vomiting
  7. Adjustment disorder with depressed mood
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  10. Diarrhoea

50-59:

  1. Burning sensation
  2. Chest pain
  3. Hypersensitivity
  4. Impaired healing
  5. Local swelling (swelling at the site of some application of substance or injury)
  6. Loss of consciousness
  7. Mass
  8. Pain
  9. Pneumonia
  10. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

60+:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. White blood cell count increased
  4. Asthenia (weakness)
  5. Asthma
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  8. Lower respiratory tract infection
  9. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  10. Platelet count increased

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 27.78%
  2. Diabetes: 4 people, 22.22%
  3. Hiv Infection: 3 people, 16.67%
  4. Adjustment Disorder With Depressed Mood: 3 people, 16.67%
  5. Nausea And Vomiting: 3 people, 16.67%
  6. Hypokalemia (low potassium): 2 people, 11.11%
  7. Anaemia (lack of blood): 2 people, 11.11%
  8. Pneumonia: 2 people, 11.11%
  9. Ill-Defined Disorder: 2 people, 11.11%
  10. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Pyrazinamide and Sertraline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pyrazinamide and Sertraline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pyrazinamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sertraline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pyrazinamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sertraline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pyrazinamide and sertraline hydrochloride (the active ingredients of Pyrazinamide and Sertraline, respectively), and Pyrazinamide and Sertraline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: